Residual endogenous insulin secretion in Japanese children with type 1A diabetes

Shigetaka Sugihara1,2, Toru Kikuchi3,2, Tatsuhiko Urakami4,2

  • 1Department of Pediatrics, Tokyo Women's Medical University Medical Center East, Tokyo, Japan.

Insights

Serum C-peptide levels decrease over time in children with type 1 diabetes, correlating with higher HbA1c. Few patients maintain C-peptide levels, with responders often being adolescent females with specific HLA haplotypes.

Area of Science:

  • Endocrinology
  • Immunology
  • Pediatric Diabetes Research

Background:

  • Serum C-peptide immunoreactivity (CPR) is a marker of endogenous insulin production in type 1 diabetes.
  • Assessing CPR trends over time is crucial for understanding disease progression and potential for residual beta-cell function.

Purpose of the Study:

  • To investigate changes in serum C-peptide immunoreactivity (CPR) levels in children with type 1 diabetes over time.
  • To correlate CPR levels with glycemic control (HbA1c) and identify characteristics of patients with sustained insulin production.

Main Methods:

  • Analysis of longitudinal data from a multi-center nationwide type 1 diabetes study.
  • Measurement of serum CPR levels at two distinct periods (2013/2014 and 2016/2017).
  • Correlation analysis between CPR, HbA1c, duration since diagnosis, age, and HLA genotype.

Main Results:

  • CPR levels significantly decreased with longer duration since type 1 diabetes diagnosis.
  • Higher HbA1c levels were associated with lower CPR (< 0.1 or < 0.3 ng/mL).
  • A small subset of patients ('Responders') maintained CPR ≥ 0.6 ng/mL, predominantly adolescent females with HLA DR4-DQ4.

Conclusions:

  • Endogenous insulin production declines significantly over time in most children with type 1 diabetes.
  • Sustained CPR is rare and may be associated with specific demographic and genetic factors.
  • Transition to adult care may pose challenges for glycemic control due to depleted insulin secretion.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.3K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
412
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.9K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.7K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.2K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.1K